Finance

Lists
Why is NMTC up 13.69%?
Dive Deeper
NMTC:NASDAQ
Neuroone Medical Technologies Corp
$1.12
+13.69%
(+0.13) 1D
$1.10
-1.79% (-0.020)
After hours
Closed: Oct 2, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NMTC...
Open
$0.98
High
$1.20
Low
$0.97
Mkt. cap
10.15M
Avg. vol.
595.27K
Volume
201.38K
52-wk high
$6.96
52-wk low
$0.96
EPS
-$0.84
Beta
0.77
Shares outstanding
9.11M
No. of employees
18
Open
$0.98
High
$1.20
Low
$0.97
Mkt. cap
10.15M
Avg. vol.
595.27K
Volume
201.38K
52-wk high
$6.96
52-wk low
$0.96
EPS
-$0.84
Beta
0.77
Shares outstanding
9.11M
No. of employees
18
News stories
From web sources and news partners
About Neuroone Medical Technologies Corp
CEO-
Employees18
Founded2009
HeadquartersEden Prairie, Minnesota, United States
SectorMedical device
Websitenmtc1.com
Analyst ratings
Based on 3 analysts giving stock ratings to NMTC in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NMTC in the last 3 months.
Highest
Current $1.12
$8.80 (+685.71%)
Average
$7.27 (+549.11%)
Lowest
$5.00 (+346.43%)
Analyst
Recommendation
Action
Price target
Projected
Date
Justin Walsh
JonesTrading
Buy
Reiterated
$8.00
+614.3%
08/18/2026
Anthony Vendetti
Maxim Group
Buy
Maintained
$5.00
+346.4%
08/14/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Reiterated
$8.80
+685.7%
08/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.74M
2.89M
2.39M
1.97M
Cost of goods sold
2.33M
2.71M
2.57M
2.22M
Cost of revenue
2.33M
2.71M
2.57M
2.22M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.78M
1.89M
1.92M
2.18M
Operating expense
4.78M
1.89M
1.92M
2.18M
Total operating expenses
7.11M
4.60M
4.49M
4.40M
Operating income
-1.37M
-1.71M
-2.10M
-2.42M
Other non operating income
1.16M
4.68K
446.00
279.00
EBT including unusual items
-1.62M
-1.44M
-2.09M
-2.01M
EBT excluding unusual items
-519.80K
-1.66M
-2.08M
-2.41M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
3.00M
-
-
-
Net income
-1.62M
-1.44M
-2.09M
-2.01M
Net profit margin
-28.20%
-49.71%
-87.22%
-101.68%
Earnings per share
-
-
-
-
Interest and investment income
-
42.00K
23.00K
12.00K
Interest expense
-304.00K
-
-
-
Net interest expenses
-304.00K
42.00K
23.00K
12.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.31M
-1.64M
-2.04M
-2.38M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps